Therefore, ICP gene expression is used to select tumor patients that may benefit from immune checkpoint blockage (ICB) therapy (77). Our results showed that the expression of ALKBH5 was closely related to MSI, TMB, and neoantigens in various tumors. This evidence concerns the gene ALKBH5 and neoplasm.